Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Rheumatology International|April 12, 2018
The Turkish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Erkan Demirkaya, Seza Ozen, Betul Sozeri, et al.
Annals of the Rheumatic Diseases|July 13, 2019
Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritisFrancesca Minoia, Francesca Bovis, Sergio Davì, et al.
RMD Open|July 5, 2025
Clusters in paediatric Behçet's disease: a multicentre international studyUmmusen Kaya Akca, Farhad Shahram, Erdem Karabulut, et al.
Clinical and Experimental Rheumatology|January 29, 2011
The distribution of juvenile idiopathic arthritis in the eastern Mediterranean: results from the registry of the Turkish Paediatric Rheumatology AssociationErkan Demirkaya, Seza Ozen, Yelda Bilginer, et al.
Arthritis Research & Therapy|April 9, 2016
Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever--a randomized controlled noninferiority trialAdem Polat, Cengizhan Acikel, Betul Sozeri, et al.
Clinical and Experimental Rheumatology|October 30, 2016
A novel assessment tool for clinical care of patients with autoinflammatory disease: juvenile autoinflammatory disease multidimensional assessment reportDilek Konukbay, Marco Gattorno, Dilek Yildiz, et al.
The Journal of Pediatrics|April 9, 2021
Thrombotic Microangiopathy Associated with Macrophage Activation Syndrome: A Multinational Study of 23 PatientsFrancesca Minoia, Jessica Tibaldi, Valentina Muratore, et al.
Lupus|January 16, 2024
Rhupus syndrome in children: A multi-center retrospective cohort study and literature reviewSeher Sener, Ezgi Deniz Batu, Sezgin Sahin, et al.
Rheumatology (Oxford, England)|August 14, 2025
How early is early for JIA? Insights from the infantile-onset juvenile idiopathic arthritis patients of the PERA research group cohortKubra Ozturk, Tuncay Aydin, Gulcan Ozomay Baykal, et al.
Annals of the Rheumatic Diseases|October 1, 2018
Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trialsNicolino Ruperto, Hermine I Brunner, Pierre Quartier, et al.
Pageof 5